
HSIC • NASDAQ
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold HSIC in your mock portfolio yet.
Henry Schein’s valuation (PE ~24x on EPS of 3.17) implies the market is pricing in steady, but not hyper‑growth, earnings. Without evidence of accelerating revenue or margin expansion, the current multiple looks fair to slightly rich for a mature healthcare distributor. Profitability appears solid and consistent, but not compellingly cheap or clearly mispriced.
The stock is trading at $76.82, modestly above its 200‑day moving average of $69.53, and is up 4.3% over the last month, indicating a constructive but not overheated uptrend. An RSI of 58.51 shows positive momentum without entering overbought territory. Overall, technicals lean slightly positive but not strongly enough to shift the overall view beyond neutral.
Alternative data for Henry Schein is mildly positive, with job postings up 9.5% month over month and social media followings generally inching higher. Flat web traffic suggests stable customer engagement rather than acceleration, but hiring growth often signals management confidence and planned expansion. Overall, these signals tilt modestly bullish for business momentum and brand strength.
Combining fundamentals, technicals, and alternative data, Henry Schein appears to be in a stable, modestly improving position without clear evidence of either significant undervaluation or imminent downside. Technicals and alternative data lean positive, but the valuation and lack of visible acceleration in core financial metrics temper enthusiasm. Overall, the stock currently merits a neutral stance with a slight constructive bias.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Key moves vs recent baseline (last day / last week)
Plain-English summary of the biggest drivers (informational)
Potential risk factors to review
Based on earnings timing, volatility, liquidity and crowd activity. Informational signals only — not investment advice.
Reassess your thesis if any of these occur: